Following treatment with Yoda1 (a Piezo1 activator) and GsMTx4 (a Piezo1 inhibitor), the authors observed a significant reversal in the migratory capacity and velocity of HCC cells, which were influenced by different levels of substrate stiffness. This evidence concerns the gene PIEZO1 and hepatocellular carcinoma.